Kurt A. Schalper
12 Podcast Episodes
Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Go online to PeerView.com/EZK860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jul 2022
•
1hr 27mins
Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Go online to PeerView.com/EZK860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jul 2022
•
1hr 27mins
Similar People
Jennifer Wargo
Axel Grothey
Tanios Bekaii-Saab
Ghassan Abou-Alfa
Josep Tabernero
Donald Harvey
Ezra Cohen
Joshua Bauml
Jared Weiss
Benjamin Levy
Barbara Barnes
Leslie Kean
Nirav Shah
Steven B. Deitelzweig
Kathryn Beal
Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Kurt A. Schalper, MD, PhD - Decoding the Latest Evidence and Practical Recommendations on Biomarker Testing for New Therapeutic Options Targeting HER2, HER3, and TROP2 in Solid Tumors
Go online to PeerView.com/EZK860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
4 Jul 2022
•
1hr 27mins
Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Go online to PeerView.com/KCV860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
25 May 2022
•
1hr 26mins
Most Popular
Elon Musk
Barack Obama
Bill Gates
LeBron James
Mark Cuban
Michelle Obama
Melinda Gates
Arnold Schwarzenegger
Kevin Hart
Terry Crews
Mike Tyson
Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Go online to PeerView.com/KCV860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
25 May 2022
•
1hr 26mins
Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Kurt A. Schalper, MD, PhD - Progress and Practicalities in Immunotherapy Biomarker Testing and Pathologic Response Assessment in Solid Tumors: What’s New and What You Need to Know and Do
Go online to PeerView.com/KCV860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
25 May 2022
•
1hr 26mins
Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Go online to PeerView.com/QRC860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
5 Nov 2021
•
1hr 26mins
Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Go online to PeerView.com/QRC860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
5 Nov 2021
•
1hr 26mins
Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Kurt A. Schalper, MD, PhD - Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
Go online to PeerView.com/QRC860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
5 Nov 2021
•
1hr 26mins
Kurt A. Schalper, MD, PhD / Shanu Modi, MD - HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
Kurt A. Schalper, MD, PhD / Shanu Modi, MD - HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
Go online to PeerView.com/FFU860 to view the activity, download slides and practice aids, and complete the post-test to ... Read more
11 Jun 2021
•
51mins
